Effects of Alpha-Lipoic Acid Supplementation on Cardiovascular Disease Risk Factors in β-Thalassemia Major Patients: A Clinical Trial Crossover Study

References

• Haghi M, Poolady N, Hosseinpoor Faizi M, Hosseinpoor Faizi A. Beta thalassemia in Iran. J Shaheed Sadoughi Univ Med Sci. 2010;18(2):127–133.
   Google Scholar
• Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007;9(6):372–377. doi:10.1097/GIM.0b013e318065a9e817575503
   PubMed Web of Science ®Google Scholar
• Muncie HL, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009;80(4):339–344.19678601
   PubMed Web of Science ®Google Scholar
• Malik S, Syed S, Ahmed N. Complication in transfusion-dependent patients of B-thalassemia major. Pak J Med Sci. 2009;45(4):678–682.
   Google Scholar
• Vechio C, Derchi G. Management of cardiac complication in patients with thalassemia major. Semin Hematol. 1995;32(4):283–296.
   Web of Science ®Google Scholar
• Mente A, Chalcraft K, Ak H, et al. the relationship between trimethylamine-N-oxide and prevalent cardiovascular disease in a multiethnic population living in Canada. Can J Cardiol. 2015;31(9):1189–1194. doi:10.1016/j.cjca.2015.06.01626239008
   PubMed Web of Science ®Google Scholar
• Sherief LM, Dawood O, Ali A, et al. Premature atherosclerosis in children with beta-thalassemia major: new diagnostic marker. BMC Pediatr. 2017;17(69):1–8. doi:10.1186/s12887-017-0820-128056921
   PubMed Web of Science ®Google Scholar
• Ragab SM, Safan MA, Obeid OM, Sherief AS. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children. Hematology. 2015;20(4):228–238. doi:10.1179/1607845414Y.000000018025056687
   PubMed Web of Science ®Google Scholar
• Ozdem S, Kupesiz A, Yesilipek A. Plasma homocysteine levels in patients with β-thalassaemia major. Scand J Clin Lab Invest. 2008;68(2):134–139. doi:10.1080/0036551070151634318382931
   PubMed Web of Science ®Google Scholar
• Wollin SD, Jones PJ. Alpha-lipoic acid and cardiovascular disease. J Nutrition. 2003;133(11):3327–3330. doi:10.1093/jn/133.11.332714608040
   PubMed Web of Science ®Google Scholar
• Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161–1208. doi:10.2174/092986705376463515892631
   PubMed Web of Science ®Google Scholar
• Akbari M, Ostadmohammadi V, Tabrizi R, et al. The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab (Lond). 2018;15(1):39. doi:10.1186/s12986-018-0274-y29930690
   PubMed Web of Science ®Google Scholar
• Fontani F, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1/2 signalling. Calcif Tissue Int. 2015;96(4):335–346. doi:10.1007/s00223-015-9961-025660312
   PubMed Web of Science ®Google Scholar
• Hu H, Wang C, Jin Y, et al. Alpha-lipoic acid defends homocysteine-induced endoplasmic reticulum and oxidative stress in HAECs. Biomed Pharmacother. 2016;80:63–72. doi:10.1016/j.biopha.2016.02.02227133040
   PubMed Web of Science ®Google Scholar
• Zhang Y, Han P, Wu N, et al. Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects. Obesity (Silver Spring). 2011;19(8):1647–1653. doi:10.1038/oby.2011.12121593803
   PubMed Web of Science ®Google Scholar
• Tayebi-Khosroshahi H, Dehgan R, Habibi Asl B, et al. Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients. Iran J Kidney Dis. 2013;7(6):479–484.24241095
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Mazooji N, Roozbeh J, Hasanzade J, Mazloom Z, Aliasghari F. The effects of dietary supplementation with alpha-lipoic acid and vitamin E, individually and combined, on insulin resistance and lipid profile in hemodialysis patients. Iran J Nutr Sci Food Technol. 2013;7(4):55–62.
   Google Scholar
• Carbonelli MG, Di Renzo L, Bigioni M, Di Daniele N, De Lorenzo A, Fusco MA. Alpha-lipoic acid supplementation: a tool for obesity therapy. Curr Pharm Des. 2010;16(7):840–846. doi:10.2174/13816121079088358920388095
   PubMed Web of Science ®Google Scholar
• Wong A, Dukic-Stefanovic S, Gasic-Milenkovic J, et al. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia. Eur J Neurosci. 2001;14(12):1961–1967. doi:10.1046/j.0953-816x.2001.01820.x11860491
   PubMed Web of Science ®Google Scholar
• Cao Z, Tsang M, Zhao H, Li Y. Induction of endogenous antioxidants and Phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: protection against oxidative injury. Biochem Biophys Res Commun. 2003;310(3):979–985. doi:10.1016/j.bbrc.2003.09.11014550301
   PubMed Web of Science ®Google Scholar
• Rozas Moreno P, Reyes Garcia R, Garcia-Martin A, Varsavsky M, Garcia-Salcedo JA, Munoz-Torres M. Serum osteoprotegerin: bone or cardiovascular marker in type 2 diabetes males. J Endocrinol Invest. 2013;36(1):16–20. doi:10.3275/828522391059
   PubMed Web of Science ®Google Scholar
• Buleu FN, Luca CT, Tudor A, et al. Correlations between vascular stiffness indicators, OPG, and 25-OH vitamin D3 status in heart failure patients. Medicina (Kaunas). 2019;55(6):309. doi:10.3390/medicina55060309
   Web of Science ®Google Scholar
• Macphee CH, Nelson JJ, Zalewski A. Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target. Curr Opin Pharmacol. 2006;6(2):154–161. doi:10.1016/j.coph.2005.11.00816495153
   PubMed Web of Science ®Google Scholar
• Zalewski A, Macphee C, Nelson JJ. Lipoprotein-associated phospholipase A2: a potential therapeutic target for atherosclerosis. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5(6):527–532. doi:10.2174/15680060577496210316503872
   PubMedGoogle Scholar
• Gajos G, Zalewski J, Mostowik M, Konduracka E, Nessler J, Undas A. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A2 in patients with stable angina. Nutr Metab Cardiovasc Dis. 2014;24(4):434–439. doi:10.1016/j.numecd.2013.09.01124555913
   PubMed Web of Science ®Google Scholar
• Nelson TL, Hokanson JE, Hickey MS. Omega-3 fatty acids and lipoprotein associated phospholipase A2 in healthy older adult males and females. Eur J Nutr. 2011;50(3):185–193. doi:10.1007/s00394-010-0126-720706728
   PubMed Web of Science ®Google Scholar
• Pedersen MW, Koenig W, Christensen JH, Schmidt EB. The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults. Eur J Nutr. 2009;48(1):1–5. doi:10.1007/s00394-008-0758-z19030909
   PubMed Web of Science ®Google Scholar
• Chang JW, Lee EK, Kim TH, et al. Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study. Am J Nephrol. 2007;27(1):70–74. doi:10.1159/00009903517259696
   PubMed Web of Science ®Google Scholar
• Skulas-Ray AC, Alaupovic P, Kris-Etherton PM, West SG. Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia. J Clin Lipidol. 2015;9(3):360–367. doi:10.1016/j.jacl.2014.12.00126073395
   PubMed Web of Science ®Google Scholar
• Jameel NM, Shekhar MN, Vishwanath BS. Α-lipoic acid: an inhibitor of secretory phospholipase A2 with anti-inflammatory activity. Life Sci. 2006;80(2):146–153. doi:10.1016/j.lfs.2006.08.03217011589
   PubMed Web of Science ®Google Scholar
• Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576–585. doi:10.1038/nm.314523563705
   PubMed Web of Science ®Google Scholar
• Fukami K, Yamagishi S, Sakai K, et al. Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients. Cardiovasc Pharmacol. 2015;65(3):289–295. doi:10.1097/FJC.0000000000000197
   PubMed Web of Science ®Google Scholar
• Obeid R, Awwad HM, Kirsch SH, et al. Plasma Trimethylamine-N-oxide following supplementation with vitamin D or D plus B vitamins. Mol Nutr Food Res. 2017;61(2):1–24. doi:10.1002/mnfr.201600358
   Web of Science ®Google Scholar
• Han H, Cui M, You X, et al. A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet. Nutr Metab Cardiovasc Dis. 2015;25(6):556–561. doi:10.1016/j.numecd.2015.02.01125843661
   PubMed Web of Science ®Google Scholar
• Martin FP, Wang Y, Sprenger N, et al. Probiotic modulation of symbiotic gut microbial–host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol. 2008;4(1):157. doi:10.1038/msb410019018197175
   PubMed Web of Science ®Google Scholar
• Chen ML, Yi L, Zhang Y, et al. Resveratrol attenuates Trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. mBio. 2016;7(2):e02210–15. doi:10.1128/mBio.02210-1527048804
   PubMed Web of Science ®Google Scholar
• Boutagy NE, Neilson AP, Osterberg KL, et al. Probiotic supplementation and trimethylamine-N-oxide production following a high-fat diet. Obesity (Silver Spring). 2015;23(12):2357–2363. doi:10.1002/oby.2121226465927
   PubMed Web of Science ®Google Scholar
• Baugh ME, Steele CN, Angiletta CJ, et al. Inulin supplementation does not reduce plasma trimethylamine N-oxide concentrations in individuals at risk for type 2 diabetes. Nutrients. 2018;10(6):793. doi:10.3390/nu10060793
   Web of Science ®Google Scholar
• Tripolt NJ, Leber B, Triebl A, Kofeler H, Stadlbauer V, Sourij H. Effect of lactobacillus casei shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: an open-label, randomized study. Atherosclerosis. 2015;242(1):141–144. doi:10.1016/j.atherosclerosis.2015.05.00526188537
   PubMed Web of Science ®Google Scholar
• Angiletta CJ, Griffin LE, Steele CN, et al. Impact of short-term flavanol supplementation on fasting plasma trimethylamine-N-oxide concentrations in obese adults. Food Funct. 2018;9(10):5350–5361. doi:10.1039/C8FO00962G30264073
   PubMed Web of Science ®Google Scholar
• Pakfetrat M, Shahroodi JR, Zolgadr AA, Larie HA, Nikoo MH, Malekmakan L. Effects of zinc supplement on plasma homocysteine level in end-stage renal disease patients: a double-blind randomized clinical trial. Biol Trace Elem Res. 2013;153(1–3):11–15. doi:10.1007/s12011-013-9639-223475369
   PubMed Web of Science ®Google Scholar
• Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients. Nephrol (Carlton). 2008;13(4):284–288. doi:10.1111/j.1440-1797.2008.00934.x
   Web of Science ®Google Scholar